Skip Navigation LinksHome > November 1984 - Volume 61 - Issue 5 > The Pharmacokinetics of Sufentanil in Surgical Patients.

The Pharmacokinetics of Sufentanil in Surgical Patients.

Bovill, James G. M.D., F.F.A.R.C.S.I.; Sebel, Peter S. M.B., Ph.D., F.F.A.R.C.S.I.; Blackburn, Cordelia L. M.B., B.S., F.F.A.R.C.S.I.; Oei-Lim, Vivian M.D.; Heykants, Jos J. Ph.D.

Collapse Box


The pharmacokinetics of sufentanil, a new thienyl analogue of fentanyl, were studied in 10 surgical patients. Sufentanil, 5 [mu]g/kg, was given intravenously as a bolus injection and plasma concentrations measured at intervals up to 8 h. Plasma sufentanil concentrations decreased rapidly after injection-98% of the administered dose having left the plasma within 30 min. In 9 of the 10 patients, a tri-exponential equation optimally described the sufentanil concentration decay curve, with average (+/-SEM) half-lives for the rapid ([pi]) and slow ([alpha]) distribution phases of 1.4 +/- 0.3 min and 17.7 +/- 2.6 min, respectively. The average terminal elimination ([beta]) half-life was 164 +/- 22 min. The average value for Vd[beta] was 2.9 +/- 0.2 1/kg, Vdss 1.7 +/- 0.2 1/kg and total plasma clearance 12.7 +/- 0.8 ml [middle dot] kg-1 [middle dot] min-1 (935 +/- 50 ml/min). In one patient, a biexponential equation was sufficient to describe the concentration-time data, yielding a distribution half-life of 4.7 min and an elimination half-life of 117 min.
(C) 1984 American Society of Anesthesiologists, Inc.
Publication of an advertisement in Anesthesiology Online does not constitute endorsement by the American Society of Anesthesiologists, Inc. or Lippincott Williams & Wilkins, Inc. of the product or service being advertised.

Article Tools


Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.